Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals
暂无分享,去创建一个
Udo Kraushaar | T. Meyer | U. Kraushaar | E. Guenther | Elke Guenther | K. Stuerz | Mitsuhiro Edamura | Thomas Meyer | Katharina Stuerz | Mitsuhiro Edamura
[1] Borje Darpo,et al. ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs , 2005 .
[2] M. Peschanski,et al. Organotypic heart slices for cell transplantation and physiological studies , 2009, Organogenesis.
[3] D. McEwen,et al. Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. , 2007, Journal of molecular and cellular cardiology.
[4] M. Wilkinson,et al. Myocardial slice: a physiological approach to beta-adrenergic ([3H] CGP-12177) receptor binding in hamster and guinea pig heart. , 1989, Journal of pharmacological methods.
[5] N. Ziv,et al. Evolution of Action Potential Propagation and Repolarization in Cultured Neonatal Rat Ventricular Myocytes , 2001, Journal of cardiovascular electrophysiology.
[6] G. Terstappen. Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. , 2004, Assay and drug development technologies.
[7] A. Camm,et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.
[8] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[9] Antoni C G van Ginneken,et al. Electrophysiological properties of embryonic stem cells during differentiation into cardiomyocyte-like cell types. , 2007, Methods in molecular biology.
[10] Patrizia Camelliti,et al. Tissue Slices from Adult Mammalian Hearts as a Model for Pharmacological Drug Testing , 2009, Cellular Physiology and Biochemistry.
[11] K. Broadley,et al. The Langendorff heart preparation—Reappraisal of its role as a research and teaching model for coronary vasoactive drugs , 1979 .
[12] Jiesheng Kang,et al. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. , 2002, European journal of pharmacology.
[13] Liang Guo,et al. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation. , 2005, Journal of pharmacological and toxicological methods.
[14] C. January,et al. [3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. , 2001, European journal of pharmacology.
[15] S. Jenna,et al. Potential role of the membrane in hERG channel functioning and drug-induced long QT syndrome. , 2010, Biochimica et biophysica acta.
[16] D. Roden,et al. Cellular basis of drug‐induced torsades de pointes , 2008, British journal of pharmacology.
[17] Gan-XinYan,et al. Cellular Basis for the Electrocardiographic J Wave , 1996 .
[18] Robert Passier,et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.
[19] X. Wan,et al. hERG channel trafficking: novel targets in drug-induced long QT syndrome. , 2007, Biochemical Society transactions.
[20] Natalia Trayanova,et al. Mechanistic investigation into the arrhythmogenic role of transmural heterogeneities in regional ischaemia phase 1A. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[21] J. Hyllner,et al. Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications , 2010, Stem Cell Reviews and Reports.
[22] T. Powell,et al. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. , 1976, Biochemical and biophysical research communications.
[23] J. Ross,et al. Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.
[24] M. Peschanski,et al. An in vitro beating heart model for long-term assessment of experimental therapeutics. , 2009, Cardiovascular research.
[25] Srilakshmi M. Adhyapak,et al. Architecture of the left ventricle: insights for optimal surgical ventricular restoration , 2009, Heart Failure Reviews.
[26] B. Beer,et al. Screening for potassium channel modulators by a high through-put 86-rubidium efflux assay in a 96-well microtiter plate. , 1991, Journal of pharmacological methods.
[27] T. Meyer,et al. New cell models and assays in cardiac safety profiling. , 2007, Expert opinion on drug metabolism & toxicology.
[28] Philip J. Podrid,et al. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management , 2001 .
[29] B. Fleischmann,et al. Generation of cardiomyocytes from embryonic stem cells experimental studies. , 2002, Herz.
[30] W. Baxter,et al. Stationary and drifting spiral waves of excitation in isolated cardiac muscle , 1992, Nature.
[31] G. Nollo,et al. Adaptation of the QT interval to heart rate changes in isolated perfused guinea pig heart: influence of amiodarone and D-sotalol. , 1997, Pharmacological research.
[32] M. Laflamme,et al. Local Control of Excitation-Contraction Coupling in Human Embryonic Stem Cell-Derived Cardiomyocytes , 2009, PloS one.
[33] Lior Gepstein,et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.
[34] Hsien C Cheng,et al. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts. , 2009, Journal of pharmacological and toxicological methods.
[35] Sean P. Palecek,et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.
[36] J. Warmke,et al. Potassium Currents Expressed from Drosophila and Mouse eag cDNAs in Xenopus Oocytes , 1996, Neuropharmacology.
[37] Divya Rajamohan,et al. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. , 2010, Biochemical Society transactions.
[38] E. Bettiol,et al. Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: A Molecular and Electrophysiological Approach , 2007, Stem cells.
[39] Jean-Pierre Valentin,et al. Reducing QT liability and proarrhythmic risk in drug discovery and development , 2010, British journal of pharmacology.
[40] D. Fedida,et al. Rb+ Flux through hERG Channels Affects the Potency of Channel Blocking Drugs: Correlation with Data Obtained Using a High-Throughput Rb+ Efflux Assay , 2004, Journal of biomolecular screening.
[41] J. Randløv,et al. QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction , 2010, Diabetologia.
[42] A. Goette,et al. Electrical remodeling in atrial fibrillation. Time course and mechanisms. , 1996, Circulation.
[43] C. Kirkpatrick,et al. Assessing risk of a prolonged QT interval–a survey of emergency physicians , 2008, International journal of emergency medicine.
[44] Keitaro Hashimoto,et al. Practical application of guinea pig telemetry system for QT evaluation. , 2005, The Journal of toxicological sciences.
[45] Katriina Aalto-Setälä,et al. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype , 2010, Experimental biology and medicine.
[46] G. Duker,et al. Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic , 2001, Circulation.
[47] K. Satyshur,et al. hERG Gating Microdomains Defined by S6 Mutagenesis and Molecular Modeling , 2008, The Journal of general physiology.
[48] M. Pugsley,et al. Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. , 1994, Journal of pharmacological and toxicological methods.
[49] Jin Han,et al. Ketamine abolishes ischemic preconditioning through inhibition of K(ATP) channels in rabbit hearts. , 2002, American journal of physiology. Heart and circulatory physiology.
[50] A M Wobus,et al. Selection of ventricular‐like cardiomyocytes from ES cells in vitro , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] L B Bugaisky,et al. Differentiation of Adult Rat Cardiac Myocytes in Cell Culture , 1989, Circulation research.
[52] C. Antzelevitch. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[53] Paul B Bennett,et al. High throughput ion-channel pharmacology: planar-array-based voltage clamp. , 2003, Assay and drug development technologies.
[54] M. Curtis,et al. Does QT Widening in the Langendorff-perfused Rat Heart Represent the Effect of Repolarization Delay or Conduction Slowing? , 2003, Journal of cardiovascular pharmacology.
[55] C Antzelevitch,et al. Cellular basis for the electrocardiographic J wave. , 1996, Circulation.
[56] L. Carlsson. In vitro and in vivo models for testing arrhythmogenesis in drugs , 2006, Journal of internal medicine.
[57] A. Moss,et al. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. , 2003, The Journal of clinical investigation.
[58] H. Suga,et al. Myocardial VO2 of mechanically unloaded contraction of rat ventricular slices measured by a new approach. , 1996, The American journal of physiology.
[59] G. Robertson,et al. HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.
[60] L. Belardinelli,et al. ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes. , 1994, The American journal of physiology.
[61] Peter Kohl,et al. Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. , 2009, Future cardiology.
[62] B. Thiers. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .
[63] J. Itskovitz‐Eldor,et al. Generation and Characterization of Functional Cardiomyocytes from Rhesus Monkey Embryonic Stem Cells , 2006, Stem cells.
[64] Wei-Shou Hu,et al. Low‐Glutamine Fed‐Batch Cultures of 293‐HEK Serum‐Free Suspension Cells for Adenovirus Production , 2003, Biotechnology progress.
[65] Leslie Tung,et al. Optical imaging of arrhythmias in tissue culture. , 2006, Journal of electrocardiology.
[66] Peter Lipp,et al. A primary culture system for sustained expression of a calcium sensor in preserved adult rat ventricular myocytes. , 2008, Cell calcium.
[67] P. Saunders,et al. The metabolism of the heart in relation to drug action; the action of metabolic inhibitors on rat heart slice respiration. , 1949, Archives of biochemistry.
[68] M. Drici,et al. Is Gender a Risk Factor for Adverse Drug Reactions? , 2001, Drug safety.
[69] R. Jaenisch,et al. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] Jean-Pierre Valentin,et al. Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. , 2004, Journal of pharmacological and toxicological methods.
[71] G. Tomaselli,et al. Cardiac Metabolism and Arrhythmias , 2009, Circulation. Arrhythmia and electrophysiology.
[72] John Dunlop,et al. hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk. , 2008, Current drug metabolism.
[73] M. Vos,et al. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs. , 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.
[74] C. Tondo,et al. Atrial fibrillation: cure or treat? , 2009, Therapeutic advances in cardiovascular disease.
[75] F. Wurm,et al. Transient Gene Expression in Suspension HEK‐293 Cells: Application to Large‐Scale Protein Production , 2008, Biotechnology progress.
[76] LimorZwi,et al. Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009 .
[77] J. Edelman,et al. Active ion transport pathways in the bovine retinal pigment epithelium. , 1990, The Journal of physiology.
[78] S. Harding,et al. Species dependence of contraction velocity in single isolated cardiac myocytes. , 1990, Cardioscience.
[79] L. Buja,et al. Quantification of beta-adrenergic receptors in canine cardiac myocytes using autoradiography and an internal standard. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[80] M. Sanguinetti,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[81] M. Memo,et al. Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs. , 1989, The Journal of physiology.
[82] J. Valentin,et al. Nonclinical proarrhythmia models: predicting Torsades de Pointes. , 2005, Journal of pharmacological and toxicological methods.
[83] M. Vos,et al. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. , 2007, Cardiovascular research.
[84] J. Hescheler,et al. Ventricular Slices of Adult Mouse Hearts - a new Multicellular In Vitro Model for Electrophysiological Studies , 2006, Cellular Physiology and Biochemistry.
[85] Margit Asmild,et al. Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance. , 2003, Assay and drug development technologies.
[86] D. Flockhart,et al. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. , 1998, Journal of clinical psychopharmacology.
[87] G. Keller,et al. Mechanisms of drug induced QT interval prolongation. , 2010, Current drug safety.
[88] Wilhelm Bloch,et al. Neonatal Murine Heart Slices. A Robust Model to Study Ventricular Isometric Contractions , 2007, Cellular Physiology and Biochemistry.
[89] M. Sanguinetti. ION CHANNELS , RECEPTORS AND TRANSPORTERS HERG 1 channelopathies , 2010 .
[90] Charles Antzelevitch,et al. Transseptal Dispersion of Repolarization and Its Role in the Development of Torsade de Pointes Arrhythmias , 2010, Journal of cardiovascular electrophysiology.
[91] G. Ferrier,et al. Transient inward current is conducted through two types of channels in cardiac Purkinje fibres. , 1996, Journal of molecular and cellular cardiology.
[92] P. Hoffmann,et al. Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends. , 2006, Journal of pharmacological and toxicological methods.
[93] S. Yuasa,et al. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era , 2008, Expert review of cardiovascular therapy.
[94] P. Williams. The role of pharmacological profiling in safety assessment. , 1990, Regulatory toxicology and pharmacology : RTP.
[95] Kumaraswamy Nanthakumar,et al. Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. , 2007, American journal of physiology. Heart and circulatory physiology.
[96] Jules C Hancox,et al. Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. , 2002, Journal of pharmacological and toxicological methods.
[97] E. Carmeliet. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart. , 1980, European journal of pharmacology.
[98] A J Levi,et al. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. , 1998, Cardiovascular research.
[99] C. Antzelevitch,et al. Fever Accentuates Transmural Dispersion of Repolarization and Facilitates Development of Early Afterdepolarizations and Torsade de Pointes Under Long-QT Conditions , 2008, Circulation. Arrhythmia and electrophysiology.
[100] A. Bass,et al. New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age. , 2004, Journal of pharmacological and toxicological methods.
[101] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[102] Gary A Gintant,et al. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o. , 2004, Journal of pharmacological and toxicological methods.
[103] M. Bootman,et al. Comparison of the T-tubule system in adult rat ventricular and atrial myocytes, and its role in excitation-contraction coupling and inotropic stimulation. , 2010, Cell calcium.
[104] B. Siegmund,et al. Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. , 1991, Journal of molecular and cellular cardiology.
[105] O. Langendorff,et al. Untersuchungen am überlebenden Säugethierherzen , 1898, Archiv für die gesamte Physiologie des Menschen und der Tiere.
[106] T. McQuinn,et al. Embryogenesis of the heart muscle. , 2008, Heart failure clinics.
[107] M. Davies,et al. Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C* , 2001, The Journal of Biological Chemistry.
[108] J. Hescheler,et al. Impulse propagation in late-stage embryonic and neonatal murine ventricular slices. , 2006, Journal of electrocardiology.
[109] Derek Leishman,et al. Towards a drug concentration effect relationship for QT prolongation and torsades de pointes. , 2002, Current opinion in drug discovery & development.
[110] S. Nattel,et al. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. , 2008, Cardiovascular research.
[111] C. Doe,et al. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs. , 2002, Journal of pharmacological and toxicological methods.
[112] L. Samuelson,et al. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. , 1996, Circulation research.
[113] Burnashev Na,et al. The use of thin slices of myocardium for recording the currents across single ion channels , 1991 .
[114] A. Grace,et al. Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts , 2008, Experimental physiology.
[115] Antranig Basman,et al. HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study. , 2004, Progress in biophysics and molecular biology.
[116] W. Crumb,et al. Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. , 2004, Journal of pharmacological sciences.
[117] Soo Sen Lee,et al. Flux assays in high throughput screening of ion channels in drug discovery. , 2003, Assay and drug development technologies.
[118] P. Daleau,et al. Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes. , 1994, Circulation research.
[119] 田中 智文,et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes , 2012 .
[120] M. Sanguinetti,et al. Molecular and Cellular Mechanisms of Cardiac Arrhythmias , 2001, Cell.
[121] Yuan-yuan Wang,et al. Knock-In Mouse Model of Dilated Cardiomyopathy Caused by Troponin Mutation , 2007, Circulation research.